Episode 133: Clinical Conversations: Understanding CKM Syndrome in Obesity Care

In this episode of Obesity: A Disease, presented by the Obesity Medicine Association (OMA) in collaboration with the American Heart Association (AHA), Dr. Chiadi Ndumele joins the discussion to explore Cardiovascular-Kidney-Metabolic (CKM) Syndrome and its implications for obesity care. Learn how the CKM framework and staging system can help clinicians assess cardiovascular risk, identify opportunities for early intervention, and develop individualized treatment strategies. The conversation also examines the impact of weight loss on cardiometabolic outcomes and the role of lifestyle interventions, anti-obesity medications, and bariatric surgery in improving long-term health.

Episode Guest:

Chiadi Ndumele, MD, PhD, MHS

Episode Host:

Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP

Chapters

• (00:00:01) - Introduction and Case Presentation
• (00:01:05) - Guest Introduction: Dr. Ndumele's Background
• (00:02:29) - What is Cardiovascular Kidney Metabolic (CKM) Syndrome?
• (00:03:50) - Shifting Drivers of Cardiometabolic Disease
• (00:04:55) - Underlying Pathophysiology: Inflammation and Insulin Resistance
• (00:05:48) - How CKM Guidelines Address Interconnected Risk
• (00:07:21) - CKM Staging System Explained
• (00:11:14) - Risk Progression, Synergy, and Mortality
• (00:12:12) - Metrics for Assessing CKM Risk
• (00:14:11) - Fatty Liver Disease and the Fib-4 Index
• (00:14:57) - Using the PREVENT Score and Add-On Variables
• (00:15:57) - Social Deprivation and Health Equity in CKM
• (00:17:04) - Obesity as a Centerpiece of Cardiometabolic Risk
• (00:18:11) - How Much Weight Loss Matters for Cardiometabolic Health
• (00:20:28) - GLP-1 Agents and Weight-Independent Cardiovascular Benefits
• (00:21:42) - Key Takeaways for Non-Cardiologist Clinicians
• (00:24:38) - Closing Thoughts and Sign-Off